Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RISPERIDONE Cause Intensive care unit acquired weakness? 14 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Intensive care unit acquired weakness have been filed in association with RISPERIDONE (Risperidone). This represents 0.0% of all adverse event reports for RISPERIDONE.

14
Reports of Intensive care unit acquired weakness with RISPERIDONE
0.0%
of all RISPERIDONE reports
0
Deaths
14
Hospitalizations

How Dangerous Is Intensive care unit acquired weakness From RISPERIDONE?

Of the 14 reports, 14 (100.0%) required hospitalization, and 14 (100.0%) were considered life-threatening.

Is Intensive care unit acquired weakness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does RISPERIDONE Cause?

Gynaecomastia (24,453) Off label use (10,376) Abnormal weight gain (9,418) Weight increased (6,885) Emotional disorder (5,809) Product use in unapproved indication (5,551) Drug ineffective (5,232) Injury (4,447) Hyperprolactinaemia (4,124) Galactorrhoea (3,513)

What Other Drugs Cause Intensive care unit acquired weakness?

METHYLPREDNISOLONE (57) PROPOFOL (55) MIDAZOLAM (49) PREDNISOLONE (47) PREDNISONE (45) MYCOPHENOLATE MOFETIL (42) THIOPENTAL (41) FENTANYL (40) LEVETIRACETAM (40) VANCOMYCIN (37)

Which RISPERIDONE Alternatives Have Lower Intensive care unit acquired weakness Risk?

RISPERIDONE vs RITALIN RISPERIDONE vs RITLECITINIB RISPERIDONE vs RITODRINE RISPERIDONE vs RITONAVIR RISPERIDONE vs RITUXAN

Related Pages

RISPERIDONE Full Profile All Intensive care unit acquired weakness Reports All Drugs Causing Intensive care unit acquired weakness RISPERIDONE Demographics